Health and Healthcare
5864 Articles
New oil projects are being scrapped in Norway amid falling production and low oil prices.
Bellicum Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering.
SunTrust Robinson Humphrey analysts say in a research note that Achaogen and Cempra could be in play as acquisition targets.
Merck will acquire Cubist for $102 a share, or, about $9.5 billion, including $1.1 billion in Cubist’s net debt and…
MannKind saw its shares trading lower on Thursday. The culprit may simply be insiders selling more shares.
Array BioPharma has announced that it had reached a definitive agreement with Novartis to regain full worldwide rights to cancer…
Credit Suisse has released a biotech research report that has their top picks for upside potential in the biotech segment…
Avanir Pharmaceuticals announced that it has entered into a definitive agreement with Otsuka Pharmaceutical for a $17.00 per share buyout.
At least five upcoming dates could be big days in December, for better or worse, for individual biotech stocks.
The week after the Thanksgiving holiday stacks up to be another quiet one on the IPO front.
ThinkstockThe short interest data are out for the November 14 settlement date. Biotech companies are considered a riskier group of…
ThinkstockAmgen Inc. (NASDAQ: AMGN) announced the termination of all Amgen-sponsored clinical studies of rilotumumab in advanced gastric cancer. This includes…
Monday may have started out as a fairly quiet news day for most stock sectors on a shortened week, but…
24/7 Wall St. has identified five of the lowest performing health care stocks over the past month which need to…
As the Stifel health care conference continues, the firm posts four more stocks that it rates Buy that have incredible…
Our top personal finance-related articles today. Your wallet will thank you later.